Drug seizure irritant to be addressed soon
A senior European Union representative said here today that the body would soon change its Customs laws to address the issue of seizures of Indian generic drug shipments while en route for export to other countries.
This comes a few days after commerce and industry minister Anand Sharma threatened to take the EU to the World Trade Organisation's appellate tribunal on the issue.
Apart from changing its rules to avoid such incidents, the representative, Daniele Smadja, head of a visiting delegation of the European Commission, the EU’s executive body, also said trade ministers from there and India would be meeting by the end of June or early July to review the ongoing negotiations on a free trade agreement (FTA). The agreement is expected to be in place by October.
The interception of generic drugs from India started almost two years earlier, when a shipment en route to Brazil was seized by the Dutch customs during transit, by citing alleged violation of European patent laws.
“The issue (seizure of drugs) has just happened once but we are making sure that it never happens again, so we are changing one of our regulations in order to make sure that there is no confusion in the minds of our customs. We are in the process and contemplating some clarification of our internal European legislation to make sure customs have clear instructions and that no such problems take place,” Smadja told reporters here.
She said the generic drugs issue was being discussed in the context of the FTA. "We have both agreed that in the IPR chapter, there should be no limit of the Indian capacity to produce and export life-saving medicines."
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
